These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10116674)

  • 1. Adverse drug reaction surveillance and risk management.
    Johnston PE
    Perspect Healthc Risk Manage; 1992; 12(2):22-4. PubMed ID: 10116674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Criteria-based adverse drug reaction reporting and the use of a relational database.
    Hatton RC
    Top Hosp Pharm Manage; 1992 Jul; 12(2):40-8. PubMed ID: 10128728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A successful community hospital program for monitoring adverse drug reactions.
    Saine DR
    Top Hosp Pharm Manage; 1992 Jul; 12(2):19-30. PubMed ID: 10128726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse drug reaction reporting system: developing a well-monitored program.
    Kilarski DJ; Ziegler B; Coarse J; Buchanan C
    Hosp Formul; 1986 Sep; 21(9):949-52. PubMed ID: 10289704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can a multidisciplinary initiative to increase adverse drug reaction reporting work?
    Perkerson KA; Quercia RA; Goldman M; Goddu G; Coleman CI
    Conn Med; 2004 May; 68(5):281-4. PubMed ID: 15171264
    [No Abstract]   [Full Text] [Related]  

  • 6. A team approach to adverse drug reaction surveillance: success at a tertiary care hospital.
    Saltiel E; Johnson E; Shane R
    Hosp Formul; 1995 Apr; 30(4):226-8, 231-2. PubMed ID: 10141866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An adverse drug reaction reporting program in a community hospital.
    Tse CS; Madura AJ
    QRB Qual Rev Bull; 1988 Nov; 14(11):336-40. PubMed ID: 3144689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revised ADR report permits internal review of drug experience.
    Jeffrey LP
    Pharm Times; 1986 Dec; 52(12):48-50. PubMed ID: 10317827
    [No Abstract]   [Full Text] [Related]  

  • 9. Hospital pharmacy compliance with JCAHO standards and ASHP guidelines for reporting adverse drug reactions.
    Tyler LS; Nickman NA
    Am J Hosp Pharm; 1992 Apr; 49(4):845-50. PubMed ID: 1595720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adapting a commercially available software program to improve ADR reporting.
    Ries AJ; Kraynak MA
    Formulary; 1995 Nov; 30(11):697-8, 703-4. PubMed ID: 10152873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a database computer program to identify trends in reporting of adverse drug reactions.
    Johnston PE; Morrow JD; Branch RA
    Am J Hosp Pharm; 1990 Jun; 47(6):1321-7. PubMed ID: 2368725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacy-coordinated program that encourages physician reporting of adverse drug reactions.
    Gilroy GW; Scollins MJ; Gay CA; Harry DJ; Giannuzzi DF
    Am J Hosp Pharm; 1990 Jun; 47(6):1327-33. PubMed ID: 2368726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A description of a successful computerized adverse drug reaction tracking program.
    Maliekal J; Thornton J
    Hosp Formul; 1990 Apr; 25(4):436-9, 442. PubMed ID: 10104234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the development of a multidisciplinary adverse drug reaction committee.
    Etzel JV; Brocavich JM; Rousseau M
    Hosp Pharm; 1995 Dec; 30(12):1083-7. PubMed ID: 10153655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality improvement in the use of medications through a drug use evaluation service.
    Stevenson JG; Bakst CM; Zaran FK; Rybak MJ; Smolarek RT; Alexander MR
    Top Hosp Pharm Manage; 1992 Oct; 12(3):47-56. PubMed ID: 10128747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A survey of adverse drug reaction reporting programs in select hospitals.
    Case RL; Guzzetti PJ
    Hosp Pharm; 1986 May; 21(5):423-6, 431-4, 438. PubMed ID: 10276799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional teams lead to Joint Commission success.
    Weller D; Johnson D; McDonald E; Mooney K; O'Neill MS; Winterhalter A; Yackanich R
    J Nurs Care Qual; 1997 Dec; 12(2):14-26. PubMed ID: 9397636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in the approval process for the physician computerized signature.
    Lima C
    J AHIMA; 1993 Feb; 64(2):55-8. PubMed ID: 10123922
    [No Abstract]   [Full Text] [Related]  

  • 19. Improved reporting of adverse drug reactions.
    Kimelblatt BJ; Young SH; Heywood PM; Mandala AR; Gendelman S; Mehl B
    Am J Hosp Pharm; 1988 May; 45(5):1086-9. PubMed ID: 3400650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring compliance with JCAHO standards using a medication-control review tool.
    Kowiatek JG; Weber RJ; Schilling DE; McKaveney TP
    Am J Health Syst Pharm; 2002 Sep; 59(18):1763-7. PubMed ID: 12298115
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.